3.0
Mar 3, 2024
Current employee, more than 5 years
Jakarta
Recommend
CEO approval
Business Outlook
Pros
Great product, great scientific based approach
Cons
Political interest in senior leadership. Selling premium drugs in which very segmented market in asia